LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Average Rating of "Moderate Buy" from Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $8.30.

Several research analysts recently issued reports on LFST shares. Canaccord Genuity Group started coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 target price on the stock. KeyCorp initiated coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective on the stock. Finally, William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th.

LifeStance Health Group Stock Down 0.7%

Shares of NASDAQ:LFST opened at $5.63 on Friday. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of -21.65 and a beta of 1.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group has a 12-month low of $4.64 and a 12-month high of $8.61. The business's 50 day moving average is $6.44 and its 200 day moving average is $7.19.

Insiders Place Their Bets

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares of the company's stock, valued at approximately $2,344,689. The trade was a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.20% of the company's stock.

Institutional Trading of LifeStance Health Group

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of LifeStance Health Group by 5.0% in the first quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock valued at $74,733,000 after buying an additional 531,841 shares during the period. Jennison Associates LLC raised its stake in shares of LifeStance Health Group by 2.1% in the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock valued at $54,980,000 after buying an additional 168,856 shares during the period. Wellington Management Group LLP raised its stake in shares of LifeStance Health Group by 2.3% in the first quarter. Wellington Management Group LLP now owns 5,399,293 shares of the company's stock valued at $35,959,000 after buying an additional 123,056 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock valued at $25,977,000 after buying an additional 1,643,390 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock valued at $25,546,000 after buying an additional 13,293 shares during the period. 85.50% of the stock is currently owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.